Publications

Shinya Yamanaka, MD, PhDGeneration of naive-like porcine-induced pluripotent stem cells capable of contributing to embryonic and fetal development. View in: PubMed
Shinya Yamanaka, MD, PhDDrug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells. View in: PubMed
Shinya Yamanaka, MD, PhDHayashi Y, Saitou M, Yamanaka S. Germline development from human pluripotent stem cells toward disease modeling of infertility. Fertil Steril. 2012 Jun; 97(6):1250-9. View in: PubMed
Shinya Yamanaka, MD, PhDDonor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. View in: PubMed
Shinya Yamanaka, MD, PhDDerivation conditions impact x-inactivation status in female human induced pluripotent stem cells. View in: PubMed
Shinya Yamanaka, MD, PhDSakurai H, Yamanaka S. [Research for cell therapy by induced pluripotent stem cell]. Nihon Rinsho. 2011 Dec; 69(12):2114-8. View in: PubMed
Shinya Yamanaka, MD, PhDInduced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery. View in: PubMed
Shinya Yamanaka, MD, PhDScreening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol. 2011; 29(12):1132-44. View in: PubMed
Shinya Yamanaka, MD, PhDInduced pluripotent stem cells: past, present, and future. View in: PubMed
Shinya Yamanaka, MD, PhDLahti AL, Kujala VJ, Chapman H, Koivisto AP, Pekkanen-Mattila M, Kerkelä E, Hyttinen J, Kontula K, Swan H, Conklin BR, Yamanaka S, Silvennoinen O, Aalto-Setälä K. Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Dis Model Mech. 2012 Mar; 5(2):220-30. View in: PubMed